嘉事堂24年度业务基本盘保持稳定 将以创新为驱动力、积极拓展健康服务新边界
Quan Jing Wang·2025-05-15 12:41

Core Viewpoint - Jia Shitang aims to become a leading comprehensive service provider in pharmaceutical distribution and healthcare, focusing on meeting the medical needs of the public and fulfilling its responsibilities as a central enterprise [1] Group 1: Company Strategy and Vision - Jia Shitang has established a complete business system covering pharmaceutical wholesale, retail, logistics, and medical device supply chains, with a focus on secondary and tertiary hospitals, community medical centers, and chain pharmacies [1] - The company emphasizes its role in the "Healthy China" strategy and leverages the advantages of the China Everbright Group to enhance its position in the pharmaceutical industry [1][2] - The company aims to innovate and enhance its digital transformation in the pharmaceutical industry, optimizing supply chain management and logistics efficiency [3] Group 2: Financial Performance and Market Outlook - For the year 2024, Jia Shitang expects to achieve a revenue of 24.019 billion yuan and a net profit of 322 million yuan, maintaining a stable business foundation [2] - The pharmaceutical distribution industry in China is projected to continue expanding, driven by an aging population and increasing health awareness, leading to a growing demand for pharmaceuticals and high-value consumables [2] Group 3: Challenges and Innovations - The company is addressing challenges in the industry by focusing on digital transformation and exploring innovative cooperation models with internet pharmaceutical service providers [3] - Jia Shitang is actively exploring the use of drones for medical supply delivery in emergency situations to overcome ground transportation bottlenecks [3] Group 4: Future Development Goals - In 2025, Jia Shitang aims to achieve the goals of the "14th Five-Year Plan" and contribute to the global health sector by enhancing its information technology and resource potential [4] - The company plans to expand its rehabilitation medical business and develop its own health service brand, focusing on customer needs in the health service sector [4][5]

GUANGDONG DRIVE BIO-TECH CO.-嘉事堂24年度业务基本盘保持稳定 将以创新为驱动力、积极拓展健康服务新边界 - Reportify